Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: an updated systematic review and meta-analysis - Scorecard - MDSpire

Infection risk reduction with povidone-iodine rectal disinfection prior to transrectal prostate biopsy: an updated systematic review and meta-analysis

  • By

  • Ichiro Tsuboi

  • Akihiro Matsukawa

  • Mehdi Kardoust Parizi

  • Jakob Klemm

  • Stefano Mancon

  • Sever Chiujdea

  • Tamás Fazekas

  • Ekaterina Laukhtina

  • Tatsushi Kawada

  • Satoshi Katayama

  • Takehiro Iwata

  • Kensuke Bekku

  • Koichiro Wada

  • Motoo Araki

  • Shahrokh F. Shariat

  • April 23, 2024

  • 0 min

Share

Clinical Scorecard: Reducing Infection Risk Through Povidone-Iodine Rectal Disinfection Before Transrectal Prostate Biopsy: A Comprehensive Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionInfectious complications following transrectal ultrasound-guided prostate biopsy (TRUS-PB)
Key MechanismsRectal disinfection with povidone-iodine (PI) reduces bacterial translocation during TRUS-PB, lowering infection risk
Target PopulationPatients undergoing transrectal ultrasound-guided prostate biopsy
Care SettingUrology outpatient or hospital settings performing prostate biopsies

Key Highlights

  • TRUS-PB is associated with up to 6.3% incidence of infectious complications including fever, acute bacterial prostatitis, and sepsis.
  • Povidone-iodine rectal disinfection prior to TRUS-PB significantly reduces infectious complications compared to no PI use.
  • Combination of PI disinfection with antibiotic prophylaxis (AP) shows improved infection control, though efficacy in reducing sepsis requires further clarification.

Guideline-Based Recommendations

Diagnosis

  • Use clinical criteria including fever (>37.8–38.5°C) and sepsis definitions per international consensus to identify infectious complications post-TRUS-PB.

Management

  • Apply rectal disinfection with povidone-iodine prior to TRUS-PB to reduce infection risk.
  • Administer prophylactic antibiotics, commonly fluoroquinolones or β-lactams, alongside PI disinfection for enhanced protection.

Monitoring & Follow-up

  • Monitor patients post-biopsy for signs of fever and sepsis within one week.
  • Use standardized definitions for fever and sepsis to ensure consistent assessment.

Risks

  • Recognize that TRUS-PB carries a risk of infectious complications due to rectal bacterial translocation.
  • Consider antibiotic resistance patterns when selecting prophylactic antibiotics.

Patient & Prescribing Data

Patients undergoing TRUS-PB, including those receiving various prophylactic antibiotics

Most RCTs included antibiotic prophylaxis with PI disinfection; fluoroquinolones and β-lactams were common. PI plus AP reduced infection rates more than AP alone, though sepsis reduction data remain inconclusive.

Clinical Best Practices

  • Perform rectal disinfection with povidone-iodine immediately before TRUS-PB.
  • Combine PI disinfection with appropriate antibiotic prophylaxis tailored to local resistance patterns.
  • Use standardized definitions for fever and sepsis to monitor post-biopsy infectious complications.
  • Prefer transperineal biopsy when feasible, but if TRUS-PB is performed, implement PI disinfection to mitigate infection risk.

References

Original Source(s)

Related Content